Pharmaceuticals

We collaborate with the world for the health of everyone in it.
Pharma

At the Janssen Pharmaceutical Companies of Johnson & Johnson, we envision a world without disease. To achieve this, we strive to couple our strong internal capabilities with the most compelling external science to transform how diseases are thought of being treated, cured, prevented and intercepted in the future.

Focus Areas

Our Pharmaceuticals business is divided into six core areas, Cardiovascular & Metabolism; Immunology; Infectious Diseases & Vaccines; Neuroscience; Oncology; and Pulmonary Hypertension. We seek innovation across all of these areas where there is significant unmet patient need.

We are also pioneering Data Science and digital healthcare and reimagining how we Discover, Develop & Supply transformational medicines to patients around the world.

CLICK a circle below to see the diseases we are targeting.

  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
 
  •  
    Cardivascular and Thrombosis,
    Retinal Diseases,
    Metabolism/NASH,
    Renal Disease
    CARDIOVASCULAR, METABOLISM AND RETINA
    CARDIOVASCULAR, METABOLISM AND RETINA
  •  
    Gastroenterology,
    Rheumatology & Maternal-fetal immunology,
    Immuno Dermatology,
    Autoantibody pathway
    Immunology
    Immunology
  •  
    Viral Hepatitis & Adjacent Liver Diseases,
    Prevention & Treatment of Viral & Bacterial Respiratory Infections,
    Adjuvants, Novel Viral Vectors & Vaccine Technologies
    Infectious
    Diseases and Vaccines
    Infectious Diseases and Vaccines
  •  
    Mood Disorders,
    Neurodegenerative Disorders including Multiple Sclerosis,
    Schizophrenia
    Neuroscience
    Neuroscience
  •  
    Prostate Cancer,
    Hematologic Malignancies,
    Solid Tumor Targeted Therapy,
    Immuno-Oncology
    Oncology
    Oncology
  •  
    Pulmonary Hypertension (all groups), Adjacent rare cardiopulmonary diseases
    Pulmonary Hypertension
    Pulmonary Hypertension
  •  
    • Small molecule & protein therapeutics
    • mRNA & siRNA therapeutics
    • Cell & gene therapeutics
    • Data & analytics
    Discovery, Product Development & Supply
    Discovery, Product Development & Supply
  •  
    • Drug Discovery: AI & Machine Learning (ML) to drive:
    - High-value biological insights & targets
    - Reduced cycle time & improved NME quality
    • Drug Development: AI & ML to drive:
    - Improved clinical trial design, including early detection, better endpoints & patient stratification
    - Accelerated clinical trial operations
    - Enhanced Diversity & Inclusion
    • Real-World Evidence (RWE) & external control arms to augment regulatory submissions & internal decisions

    • Digital health & treatments, Software as a Medical Device & decentralized trials to enhance care
    Data Science
    Data Science
Collaboration Partners

Johnson & Johnson Innovation is comprised of a family of complementary teams that bring meaningful solutions and flexible approaches to support collaboration. From incubation facilities to early-stage investing – from venture funding to acquisition, our teams offer partners a full range of capabilities. 

Contact us

Make the Connection

We look forward to our first discussion. If you would like to discuss a collaboration,
please connect with us and we will schedule a call soon.

contact